irst.emr.it
Public cancer research and treatment institute in Emilia-Romagna, Italy, for patients, families and clinical researchers
Highlights
- New on EvolcAdded 2026-11-05
About irst.emr.it
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) is an Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), a scientific care institution focused on cancer. It is part of the regional health service of Emilia-Romagna.
The institute provides cancer care, including visit and examination booking, and runs clinical studies and new therapies. Its main audiences are cancer patients and their families, along with participants in clinical studies and attendees of its training events.
It recruits staff and publishes tenders and notices, and it accepts the "5 per mille" tax allocation in Italy.
Product: Oncology care, clinical studies and new therapies, and training events for cancer treatment.
Jobs at irst.emr.it
More health & medtech companies
isoftware.it
Software for hospital pharmacies, healthcare professionals and volunteer organizationsNew on Evolcistituto-besta.it
Neurological hospital foundation (IRCCS) providing patient care, diagnostics and neuroscience researchNew on Evolckorian.it
Residential care and home care for elderly people and people with disabilities, plus outpatient and rehab services, across ItalyNew on Evolckormed.it
Healthcare network providing specialist care, diagnostics, surgery and rehabilitation services to patients across ItalyNew on Evolclarcservizi.it
Online appointment booking and digital test-result access for patients of Gruppo Poliambulatori LARCNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
